[1] 中华医学会外科学分会胆道外科学组.急性胆道系统感染的诊断和治疗指南(2011版)[J].中华消化外科杂志社,2011,10(1):9-13.
[2] 中国医师协会急诊医师分会.中国脓毒症/脓毒性休克急诊治疗指南(2018)[J].临床急诊杂志,2018,19(9):567-588.
[3] 中国医药教育协会.抗菌药物药代动力学/药效动力学临床应用专家共识[J] .中华结核和呼吸杂志,2018,41(6):409-446.
[4] Zhou Q T, He B, Zhang C, et al.Pharmacokinetics and pharmacody namics of meropenem in elderly chinese with lower respiratory tract infections:population pharmacokinetics analysis using nonlinear mixed-effects modelling and clinical pharmacodynamies study[J] . Drugs Aging, 2011,28(11):903-912.
[5] 中华医学会呼吸病学分会感染学组.中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2018,41(4):255-280.
[6] 王明贵.2017年广泛耐药革兰氏阴性杆菌感染的实验诊断、抗菌治疗及医院感染控制:中国专家共识[J].中国感染与化疗杂志,2017,17(1):82-92.
[7] 陈 灿,应颖秋,闫盈盈,等.碳青霉烯类抗菌药物延长或持续输注治疗严重感染的疗效及安全性的系统评价[J].中国医院药学杂志,2017,37(16):1622-1634.
[8] Joel M D, Jason A R, Joshua S D, et al. A multicenter randomized trial of continuous versus intermittent β-lactam infusion in severe sepsis[J]. Am J Respir Crit Care Med,2015,192(11):1298-1305.
[9] Teo J, Liew Y, Lee W, et al. Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: a meta-analysis[J]. Int J Antimicrob Agents,2014,43(5):403-411.
[10] Rizk N A, Kanafani Z A, Tabaja H Z, et al. Extended infusion of bata-lacatam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance[J]. Expert Rev Anti Infect Ther,2017,15(7):645-652.
[11] 张译心,宋 杰,廖国林.重症监护室414株鲍曼不动杆菌耐药分析[J].武警医学,2015,26(11):1152-1154.
[12] Samir G S, Anna K G, Jurgen B B, et al. Population pharmacokinetics and pharmacodynamics of contiuous versus short-term infusion of Imipenem-Cilastain in critically Ⅲ patients in a randomized, controlled trial[J]. Int J Antimicrob Agents,2007,51:3301-3310.
[13] Suchankova H, Lips M, Urbanek K, et al. Is continuous infusion of imipenem always the best choice?[J]. Int J Antimicrob Agents.2017,49(3):348-354.
[14] 秦友发,李晓燕,邓 涛,等.亚胺培南治疗ICU血流感染给药方案结合蒙特卡洛模拟的药物经济学评价[J].中国医院药学杂志,2018,38(13):1411-1414.
[15] 王国旗,唐佩福.负压创面疗法治疗猪铜绿假单胞菌感染创面的效果[J].武警医学,2018,29(6): 595-598.